Skip to main content

Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated

  • Chapter
  • First Online:
Controversies in the Management of Gynecological Cancers

Abstract

The role of lymphadenectomy in endometrial cancer continues to provoke debate. The Mayo School advocates its use for the appropriate classification and treatment of those at risk of recurrent disease. The Manchester School argues that its use cannot be justified without clear evidence for a survival benefit. In this chapter, both sides of the debate are presented alongside a mutually agreeable trial design that has the potential to provide conclusive evidence, once and for all, for how early-stage endometrial cancer should be managed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Siegel R, Naishadham D, Jemal A. Cancer statistics 2012. CA Cancer J Clin. 2012;62:10–29.

    Article  PubMed  Google Scholar 

  2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235.

    Article  CAS  PubMed  Google Scholar 

  3. Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:3119–30.

    Article  CAS  PubMed  Google Scholar 

  4. American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65. August 2005: management of endometrial cancer. Obstet Gynecol. 2005;106:413.

    Article  Google Scholar 

  5. Creasman WT, Odicino F, Maisonneuve P, Beller U, Benedet JL, Heintz AP. Carcinoma of the corpus uteri. Int J Gynaecol Obstet. 2003;83 Suppl 1:79–118.

    Article  PubMed  Google Scholar 

  6. Gynecologic Oncology Group Surgical Procedures Manual. Revised Jan 2010. Philadelphia: Gynecologic Oncology Group; 2010.

    Google Scholar 

  7. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol. 2008;109:11–8.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Creutzberg CL, van Putten WLJ, Koper PC, et al. Survival after relapse in patients with endometrial cancer: results from a randomized trial. Gynecol Oncol. 2003;89:201–9.

    Article  PubMed  Google Scholar 

  9. Straughn JM, Huh WK, Orr Jr JW, Kelly FJ, Roland PY, Gold MA. Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol Oncol. 2003;89:295–300.

    Article  PubMed  Google Scholar 

  10. Creutzberg CL, van Putten WL, Warlam-Rodenhuis CC, van den Bergh AC, de Winter KA, Koper PC. Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial. J Clin Oncol. 2004;22:1234–41.

    Article  PubMed  Google Scholar 

  11. Larson DM, Broste SK, Krawisz BR. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet Gynecol. 1998;91:355–9.

    Article  CAS  PubMed  Google Scholar 

  12. Kitchener H, ASTEC Writing Committee. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet. 2009;373:125–36.

    Article  CAS  PubMed  Google Scholar 

  13. Benedetti Panici P, Basile S, Maneschi F. Systematic pelvic lymphadenectomy versus no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2008;100:1707–16.

    Article  PubMed  Google Scholar 

  14. Goudge C, Bernhard S, Cloven NG, Morris P. The impact of complete surgical staging on adjuvant treatment decisions in endometrial cancer. Gynecol Oncol. 2004;93(2):536–9.

    Article  PubMed  Google Scholar 

  15. Case AS, Rocconi RP, Straughn Jr JM, Conner M, Novak L, Wang W, Huh WK. A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet Gynecol. 2006;108(6):1375–9.

    Article  PubMed  Google Scholar 

  16. Todo Y, Sakuragi N, Nishida R, Yamada T, Ebina Y, Yamamoto R, Fujimoto S. Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma. Am J Obstet Gynecol. 2003;188(5):1265–72.

    Article  PubMed  Google Scholar 

  17. Mariani A, Webb MJ, Galli L. Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer. Gynecol Oncol. 2000;76:348–56.

    Article  CAS  PubMed  Google Scholar 

  18. Kumar S, Medeiros F, Dowdy SC, Keeney GL, Bakkum-Gamez JN, Podratz KC, et al. A prospective assessment of the reliability of frozen section to direct intraoperative decision making in endometrial cancer. Gynecol Oncol. 2012;127(3):525–31.

    Article  PubMed  Google Scholar 

  19. Alhilli MM, Podratz KC, Dowdy SC, Bakkum-Gamez JN, Weaver AL, McGree ME, et al. Preoperative biopsy and intraoperative tumor diameter predict lymph node dissemination in endometrial cancer. Gynecol Oncol. 2013;128(2):294–9.

    Article  PubMed  Google Scholar 

  20. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60 Suppl 8:2035–41.

    Article  CAS  PubMed  Google Scholar 

  21. Boran N, Akdag D, Halici F, Tulunay G, Turan T, Bozok S, Erdogan Z, Kose MF. A retrospective analysis of the diameter of metastatic lymph nodes in apparently early stage endometrial cancer. Tumori. 2008;94(5):681–5.

    PubMed  Google Scholar 

  22. Girardi F, Petru E, Heydarfadai M, Haas J, Winter R. Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncology. 1993;49(2):177–80.

    Article  CAS  Google Scholar 

  23. Kwon JS, Mazgani M, Miller DM, Ehlen T, et al. The significance of surgical staging in intermediate-risk endometrial cancer. Gynecol Oncol. 2011;122(1):50–4.

    Article  PubMed  Google Scholar 

  24. McMeekin DS, Lashbrook D, Gold M, Johnson G, Walker JL, Mannel R. Analysis of FIGO Stage IIIc endometrial cancer patients. Gynecol Oncol. 2001;81:273–8.

    Article  CAS  PubMed  Google Scholar 

  25. Todo Y, Kato H, Kaneuchi M, et al. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet. 2010;375:1165.

    Article  PubMed  Google Scholar 

  26. Konno Y, Todo Y, Minobe S, Kato H, Okamoto K, Sudo S, et al. A retrospective analysis of postoperative complications with or without para-aortic lymphadenectomy in endometrial cancer. Int J Gynecol Cancer. 2011;21(2):385–90.

    Article  PubMed  Google Scholar 

  27. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000;182:1506–19.

    Article  CAS  PubMed  Google Scholar 

  28. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol Oncol. 2006;101:200–8.

    Article  PubMed  Google Scholar 

  29. Watari H, Mitamura T, Moriwaki M, Hosaka M, Ohba Y, Sudo S, Todo Y, Takeda M, Ebina Y, Sakuragi N. Survival and failure pattern of patients with endometrial cancer after extensive surgery including systematic pelvic and para-aortic lymphadenectomy followed by adjuvant chemotherapy. Int J Gynecol Cancer. 2009;19(9):1585–90.

    Article  PubMed  Google Scholar 

  30. Onda T, Yoshikawa H, Mizutani K. Treatment of node-positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer. 1997;75:1836–41.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  31. Kong A, Johnson N, Kitchener HC, Lawrie TA. Adjuvant radiotherapy for stage I endometrial cancer: an updated Cochrane systematic review and meta-analysis. J Natl Cancer Inst. 2012;104(21):1625–34.

    Article  PubMed  Google Scholar 

  32. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Warlam-Rodenhuis CC. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomized trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404–11.

    Article  CAS  PubMed  Google Scholar 

  33. Mariani A, Dowdy S, Podratz KC. The role of pelvic and para-aortic lymph node dissection in the surgical treatment of endometrial cancer: a view from the USA. Obstetrician Gynaecologist. 2009;11(3):199–204.

    Article  Google Scholar 

  34. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Therapeutic role of lymph node resection in endometrial corpus cancer. Cancer. 2006;107(8):1823–30.

    Article  PubMed  Google Scholar 

  35. Smith DC, MacDonald OK, Lee CM, Gaffney DK. Survival impact of lymph node dissection in endometrial adenocarcinoma: as surveillance, epidemiology, and end results analysis. Int J Gynecol Cancer. 2008;18:255–61.

    Article  CAS  PubMed  Google Scholar 

  36. Ballester M, Dubernard G, Lécuru F, Heitz D, Mathevet P, Marret H, Querleu D, Golfier F, Leblanc E, Rouzier R, Daraï E. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO). Lancet Oncol. 2011;12:469–76.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Henry C. Kitchener MD, FRCOG, FMedSci .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag London

About this chapter

Cite this chapter

Kitchener, H.C., Butler, K.A., Crosbie, E.J., Mariani, A. (2014). Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated. In: Ledermann, J., Creutzberg, C., Quinn, M. (eds) Controversies in the Management of Gynecological Cancers. Springer, London. https://doi.org/10.1007/978-0-85729-910-9_4

Download citation

  • DOI: https://doi.org/10.1007/978-0-85729-910-9_4

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-0-85729-909-3

  • Online ISBN: 978-0-85729-910-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics